Literature DB >> 18184966

Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.

Elahna Paul, Elizabeth Thiele.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184966     DOI: 10.1056/NEJMe0707153

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer.

Authors:  Markus D Lacher; Roxana J Pincheira; Ariel F Castro
Journal:  Small GTPases       Date:  2011-07-01

2.  A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.

Authors:  Hannah Peavy; Dorothy Gail; James Kiley; Susan Shurin
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

3.  Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis.

Authors:  Michael Staehler; Matthias Sauter; Andreas Helck; Ulrich Linsenmaier; Lutz Weber; Karin Mayer; Michael Fischereder
Journal:  Int Urol Nephrol       Date:  2012-09-28       Impact factor: 2.370

4.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Authors:  Francis X McCormack; Yoshikazu Inoue; Joel Moss; Lianne G Singer; Charlie Strange; Koh Nakata; Alan F Barker; Jeffrey T Chapman; Mark L Brantly; James M Stocks; Kevin K Brown; Joseph P Lynch; Hilary J Goldberg; Lisa R Young; Brent W Kinder; Gregory P Downey; Eugene J Sullivan; Thomas V Colby; Roy T McKay; Marsha M Cohen; Leslie Korbee; Angelo M Taveira-DaSilva; Hye-Seung Lee; Jeffrey P Krischer; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

Review 5.  Using genetics and genomics strategies to personalize therapy for cancer: focus on melanoma.

Authors:  Katherine L Nathanson
Journal:  Biochem Pharmacol       Date:  2010-04-20       Impact factor: 5.858

Review 6.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

Review 7.  Plasticity and injury in the developing brain.

Authors:  Michael V Johnston; Akira Ishida; Wako Nakajima Ishida; Hiroko Baber Matsushita; Akira Nishimura; Masahiro Tsuji
Journal:  Brain Dev       Date:  2008-05-19       Impact factor: 1.961

8.  Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation.

Authors:  Samira Alliouachene; Robyn L Tuttle; Stephanie Boumard; Thomas Lapointe; Sophie Berissi; Stephane Germain; Francis Jaubert; David Tosh; Morris J Birnbaum; Mario Pende
Journal:  J Clin Invest       Date:  2008-10-09       Impact factor: 14.808

9.  Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?

Authors:  Claus Neurohr; Anna L Hoffmann; Patrick Huppmann; Vivian A Herrera; Franziska Ihle; Stefan Leuschner; Werner von Wulffen; Tobias Meis; Carlos Baezner; Hanno Leuchte; Rainer Baumgartner; Gregor Zimmermann; Juergen Behr
Journal:  Respir Res       Date:  2011-05-21

10.  Giant bilateral renal angiomyolipomas and lymphangioleiomyomatosis presenting after two successive pregnancies successfully treated with surgery and rapamycin.

Authors:  Ramón Peces; Emilio Cuesta-López; Carlos Peces; Rafael Selgas
Journal:  ScientificWorldJournal       Date:  2011-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.